Insulin-induced insulin receptor substrate-1 degradation is mediated by the proteasome degradation pathway

Citation
Xj. Sun et al., Insulin-induced insulin receptor substrate-1 degradation is mediated by the proteasome degradation pathway, DIABETES, 48(7), 1999, pp. 1359-1364
Citations number
44
Categorie Soggetti
Endocrynology, Metabolism & Nutrition","Endocrinology, Nutrition & Metabolism
Journal title
DIABETES
ISSN journal
00121797 → ACNP
Volume
48
Issue
7
Year of publication
1999
Pages
1359 - 1364
Database
ISI
SICI code
0012-1797(199907)48:7<1359:IIRSDI>2.0.ZU;2-T
Abstract
Insulin receptor substrate (IRS) proteins are important intracellular molec ules that mediate insulin receptor tyrosine kinase signaling. A decreased c ontent of IRS proteins has been found in insulin-resistant states in animal s, humans, and cultured cells under various conditions. However, the molecu lar mechanism that controls cellular levels of IRS proteins is unknown. We report that chronic insulin treatment induces the degradation of IRS-1, but not IRS-2, protein in cultured cells. The insulin-induced degradation of I RS-1 can be prevented by pretreatment with lactacystin, a specific inhibito r for proteasome degradation, These data demonstrate, for the first time, t hat insulin-induced degradation of IRS-1 is mediated by the proteasome degr adation pathway. IRS-2 can escape from the insulin-induced proteasome degra dation, suggesting the existence of specific structural requirements for th is degradation process.